The National Health Commission conducted in-depth exchanges with relevant departments and domestic and foreign pharmaceutical companies.

The China Development High-level Forum 2026 Annual Meeting "Planning for the High-Quality Development of National Health in the '15th Five-Year Plan' and Accelerating the Construction of Health China" roundtable meeting was held in Beijing on March 22. Lei Haichao, Director of the National Health Commission, attended the meeting and introduced the situation and policy issues of concern to enterprises. Officials from the National Health Commission, Medical Insurance Bureau, Traditional Chinese Medicine Bureau, Disease Control Bureau, Drug Administration Bureau, and relevant leaders from Beijing made speeches. Representatives from well-known domestic and foreign pharmaceutical companies, high-level domestic hospitals, and high-end think tanks participated in the meeting. Representatives from 8 companies raised questions and concerns, and officials from the participating departments responded.